서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 11 of 11

Issue DateTitle / Author(s) / CitationFileAltmetrics
2013-05
Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02
DOI
2015-07
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02)
DOI
2016-10
Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of doxorubicin/cyclophosphamide followed by docetaxel in breast cancer: A multicenter retrospective cohort study
DOI
2017-11
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer
DOI
2018-12
A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial
DOI
2019-01
Randomized Open Labe Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
DOI
2020-05
Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis
DOI
2021-07
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

Gelmon, Karen A.; Fasching, Peter A.; Couch, Fergus J.; Balmaña, Judith; Delaloge, Suzette; Labidi-Galy, Intidhar; Bennett, James; McCutcheon, Susan; Walker, Graham; O'Shaughnessy, Joyce; Collaborating Investigator; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Lemieux, Julie; Bazan, Fernando; Bourgeois, Hugues; Chakiba, Camille; Chehimi, Mohamad; Dalenc, Florence; De La Motte Rouge, Thibault; Frenel, Jean-Sébastien; Gonçalves, Anthony; Hardy-Bessard, Anne Claire; Lamy, Regine; Levy, Christelle; Lortholary, Alain; Mailliez, Audrey; Medioni, Jacques; Patsouris, Anne; Spaeth, Dominique; Teixeira, Luis; Tennevet, Isabelle; Villanueva, Cristian; You, Benoit; Ettl, Johannes; Gerber, Bernd; Hoffmann, Oliver; Park-Simon, Tjoung-Won; Reinisch, Mattea; Tio, Joke; Wimberger, Pauline; Boer, Katalin; Ballestrero, Alberto; Bianchini, Giampaolo; Biganzoli, Laura; Bordonaro, Roberto; Cognetti, Francesco; De Laurentiis, Michelino; De Placido, Sabino; Guarneri, Valentina; Montemurro, Filippo; Naso, Giuseppe; Santoro, Armando; Zamagni, Claudio; Kim, Seung-Jin; Nakamura, Seigo; Chae, Yee Soo; Cho, Eun Kyung; Hyun, Kim Jee; Im, Seock-Ah; Lee, Keun Seok; Park, Yeon Hee; Sohn, Joo Hyuk; Byrski, Tomasz; Huzarski, Tomasz; Kukielka-Budny, Bozena; Nowecki, Zbigniew; Szoszkiewicz, Renata; Tarnawski, Rafal; Dvornichenko, Viktoria; Moiseenko, Fedor; Mukhametshina, Guzel; Poddubskaya, Elena; Popova, Ekaterina; Tarasova, Anna; Vats, Anna; Adamo, Bárbara; Conejero, Raquel Andrés; Torres, Antonio Antón; Gelpi, Judith Balmaña; Fernández, Nieves Díaz; González, Alejandro Falcón; Garcia, Juan; Lorenzo-Lorenzo, Isabel; Antón, Fernando Moreno; Santisteban, Marta; Stradella, Agostina; Huang, Chiun-Sheng; Aksoy, Sercan; Arslan, Cagatay; Artac, Mehmet; Aydiner, Adnan; Ozyilkan, Ozgur; Sezer, Emel; Armstrong, Anne; Barrett, Sophie; Borley, Annabel; Kemp, Zoe; Michie, Caroline; Mukesh, Mukesh; Perren, Timothy; Swampillai, Angela; Young, Tammy

European Journal of Cancer, Vol.152, pp.68-77

DOI
2022-09
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial
DOI
2024-04
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Balmana, Judith; Fasching, Peter A.; Couch, Fergus J.; Delaloge, Suzette; Labidi-Galy, Intidhar; O'Shaughnessy, Joyce; Park, Yeon Hee; Eisen, Andrea F.; You, Benoit; Bourgeois, Hughes; Goncalves, Anthony; Kemp, Zoe; Swampillai, Angela; Jankowski, Tomasz; Sohn, Joo Hyuk; Poddubskaya, Elena; Mukhametshina, Guzel; Aksoy, Sercan; Timcheva, Constanta V.; Park-Simon, Tjoung-Won; Anton-Torres, Antonio; John, Ellie; Baria, Katherine; Gibson, Isabel; Gelmon, Karen A.; Koynova, Tatyana; Popov, Vasil; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Gelmon, Karen; Lemieux, Julie; Augereau, Paule; Bazan, Fernando; Becuwe, Celia; Bourgeois, Hugues; Chakiba, Camille; Chehimi, Mohamad; Cheneau, Caroline; Dalenc, Florence; de Guillebon, Eleonore; de la Motte Rouge, Thibault; Frenel, Jean-Sebastien; Goncalves, Anthony; Grenier, Julien; Hardy-Bessard, Anne Claire; Lamy, Regine; Levy, Christelle; Lortholary, Alain; Mailliez, Audrey; Medioni, Jacques; Patsouris, Anne; Spaeth, Dominique; Teixeira, Luis; Tennevet, Isabelle; Venat-Bouvet, Laurence; Villanueva, Cristian; You, Benoit; Ettl, Johannes; Fasching, Peter; Gerber, Bernd; Hanusch, Claus Alexander; Hoffmann, Oliver; Park-Simon, Tjoung-Won; Malter, Wolfram; Reinisch, Mattea; Tio, Joke; Wimberger, Pauline; Boer, Katalin; Dank, Magdolna; Ballestrero, Alberto; Bianchini, Giampaolo; Biganzoli, Laura; Bordonaro, Roberto; Cognetti, Francesco; Cortesi, Enrico; De Laurentiis, Michelino; De Placido, Sabino; Gianni, Luca; Guarneri, Valentina; Marchetti, Paulo; Montemurro, Filippo; Mosconi, Anna Maria; Naso, Giuseppe; Puglisi, Fabio; Santoro, Armando; Zamagni, Claudio; Iwata, Hiroji; Kim, Seung-Jin; Nakamura, Seigo; Chae, Yee Soo; Cho, Eun Kyung; Kim, Jee Hyun; Im, Seock-Ah; Lee, Keun Seok; Park, Yeon Hee; Sohn, Joo Hyuk; Byrski, Tomasz; Huzarski, Tomasz; Jankowski, Tomasz; Kukielka-Budny, Bozena; Lacko, Aleksandra; Nowecki, Zbigniew; Senkus-Konefka, Elzbieta; Szoszkiewicz, Renata; Tarnawski, Rafal; Andabekov, Timur; Dvorkin, Mikhail; Dvornichenko, Viktoria; Moiseenko, Fedor; Mukhametshina, Guzel; Poddubskaya, Elena; Popova, Ekaterina; Tarasova, Anna; Sakaeva, Dina; Shomova, Marina; Vats, Anna; Adamo, Barbara; Conejero, Raquel Andres; Torres, Antonio Anton; Gelpi, Judith Balmana; de Ibarguen, Blanca Cantos Sanchez; Jurado, Josefina Cruz; Fernandez, Nieves Diaz; Gonzalez, Alejandro Falcon; Garcia, Juan; Santiago, Santiago Gonzalez; Carrasco, Fernando Henao; Lorenzo, Isabel Lorenzo; Anton, Fernando Moreno; Garcia, Beatriz Rojas; Beltran, Salomon Menjon; Santisteban, Marta; Stradella, Agostina; Hou, Ming-Feng; Huang, Chiun-Sheng; Lin, Yung-Chang; Tseng, Ling-Ming; Wang, Hwei-Chung; Aksoy, Sercan; Arslan, Cagatay; Artac, Mehmet; Aydiner, Adnan; Disel, Umut; Ozkan, Metin; Ozyilkan, Ozgur; Sezer, Emel Yaman; Yetisyigit, Tarkan; Armstrong, Anne; Barrett, Sophie; Borley, Annabel; Kemp, Zoe; Michie, Caroline; Mukesh, Mukesh; Perren, Timothy; Swampillai, Angela; Chaudhry, Madhu; Young, Tammy

BREAST CANCER RESEARCH AND TREATMENT, Vol.204 No.2, pp.237-248

DOI
2024-09
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study
DOI
1